Case Study:
A top pharmaceutical company was
interested to develop a medicine for diabetes, and for which it wanted to asses
and identify attractive patient segments.
Approach
Secondary research was undertaken to
understand current diabetes treatment guidelines and therapy landscape, to
identify patient segments. Following this trial analysis was undertaken to
identify upcoming trends and molecules in different patient segments of
diabetes. The molecules and trends were further analyzed to ascertain their
expected relevance on the diabetes landscape through clinical data and
benchmark analysis. Key trends analyzed during the study were related to
epidemiology, pricing, regulatory activities, and market access regulations
across geographies. These findings were further validated through an intense
primary research involving key opinion leaders, payers, physicians and
regulatory bodies. The all inputs from primary and secondary research with
collated together and analytical tools, such as PESTLE, SWOT, ANSOFF and 5
WHY’s were used to generate insights out of the information. Final report
clearly laid out “WHERE TO PLAY” and “HOW TO PLAY” strategic options within
diabetes.
Outcome
Project helped client to clearly
understand the development opportunities within diabetes and design development
plan for molecule as per plan.
About
Cliniminds
Cliniminds is India’s leading Health
Sciences Education, Training & Consulting organization offering specialised
program in pharmaceutical data / business analytics, and other health sciences
programs. All Cliniminds programs are linked with job placements. Cliniminds
has trained and placed over 6,500 professionals in the health sciences domain.
For more information, please call 9810068241 or mail
at info@cliniminds.com;
www.cliniminds.com
No comments:
Post a Comment